1834P Exposure-efficacy analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial

Autor: Azad, A.A., Lincha, V.R., Hadigol, M., Hoffman, J., Agarwal, N., Matsubara, N., Wang, Y., DeAnnuntis, L., Zohren, F., Wang, D.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S992-S993

Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.

Autor: Bal E; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Kumar R; Institute for Cancer Genetics, Columbia University, New York, NY, USA.; Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India., Hadigol M; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Holmes AB; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Hilton LK; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Loh JW; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Dreval K; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada., Wong JCH; Centre for Lymphoid Cancer, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Vlasevska S; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Corinaldesi C; Institute for Cancer Genetics, Columbia University, New York, NY, USA., Soni RK; Proteomics and Macromolecular Crystallography Shared Resource, Columbia University, New York, NY, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA., Basso K; Institute for Cancer Genetics, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.; Genome Sciences Center, BC Cancer Research Institute, Vancouver, British Columbia, Canada., Khiabanian H; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA., Pasqualucci L; Institute for Cancer Genetics, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. lp171@cumc.columbia.edu., Dalla-Favera R; Institute for Cancer Genetics, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Genetics & Development, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.; Department of Microbiology & Immunology, Columbia University, New York, NY, USA. rd10@cumc.columbia.edu.

Publikováno v: Nature [Nature] 2022 Nov; Vol. 611 (7934), pp. E2.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nanopore sequencing with unique molecular identifiers enables accurate mutation analysis and haplotyping in the complex lipoprotein(a) KIV-2 VNTR.

Autor: Amstler, Stephan¹ (AUTHOR), Streiter, Gertraud¹ (AUTHOR), Pfurtscheller, Cathrin¹ (AUTHOR), Forer, Lukas¹ (AUTHOR), Di Maio, Silvia¹ (AUTHOR), Weissensteiner, Hansi¹ (AUTHOR), Paulweber, Bernhard² (AUTHOR), Schönherr, Sebastian¹ (AUTHOR), Kronenberg, Florian¹ (AUTHOR), Coassin, Stefan¹ (AUTHOR) Stefan.Coassin@i-med.ac.at

Publikováno v: Genome Medicine. 10/8/2024, Vol. 16 Issue 1, p1-20. 20p.

Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms.

Autor: Riedlinger G; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey., Hadigol M; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey., Khiabanian H; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey., Ganesan S; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey.; Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.; Department of Medicine, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.

Publikováno v: JAMA oncology [JAMA Oncol] 2019 Feb 01; Vol. 5 (2), pp. 265-267.